October 2, 2022 | Case-Based Roundtable Meetings Spotlight

Roundtable Discussion: Zonder Reviews Choice of Therapy for R/R Multiple Myeloma

October 20, 2022

During a Targeted Oncology case-based roundtable event, Jeffrey Zonder, MD, discussed with participants the later-line therapy options for patients who have relapsed following several lines of treatment for multiple myeloma.

Jankowitz Discusses Use of Sacituzumab Govitecan in Metastatic TNBC

October 19, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Rachel C. Jankowitz, MD, discusses the result of treatment with sacituzumab govitecan in the ASCENT trial of patients with triple-negative breast cancer.

Hamilton Discusses the Role of PARP Inhibition in Advanced Ovarian Cancer

October 18, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Chad Hamilton, MD, broke down the data that shows how the use of PARP inhibition as a first-line maintenance therapy for patients with advanced ovarian cancer is impacting patients.

Recommended Approaches to Treatment for Early-Stage HER2+ Breast Cancer

October 13, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Jennifer M. Matro, MD, discussed the data supporting systemic therapies for treatment of early-stage HER2-positive breast cancer including trastuzumab and pertuzumab.